Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection
July 12, 2021 07:00 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, July 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity
June 30, 2021 07:00 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology
June 21, 2021 07:00 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, June 21, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
June 14, 2021 14:53 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
June 14, 2021 07:00 ET
|
Enochian Biosciences, Inc.
LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that...
Enochian BioSciences объявляет о научной презентации человека с ВИЧ, демонстрирующего контролируемые уровни вируса в крови в течение 255 дней после лечения с помощью новой клеточной терапии
May 14, 2021 15:19 ET
|
Enochian Bioscience
ЛОС-АНДЖЕЛЕС, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., компания, специализирующаяся на генно-модифицированных клеточных и иммунных методах лечения инфекционных заболеваний и...
Enochian BioSciences annuncia la presentazione scientifica del caso di un soggetto affetto da HIV con livelli controllati di virus nel sangue per 255 giorni in seguito al trattamento con una nuova terapia cellulare
May 14, 2021 15:19 ET
|
Enochian Bioscience
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., un’azienda specializzata in terapie cellulari e immunitarie basate su geni modificati per la cura di malattie infettive e...
Enochian BioSciences veröffentlicht die wissenschaftliche Präsentation zu einer mit HIV infizierten Person, bei der nach der Behandlung mit einer neuartigen Zelltherapie nach 255 Tagen eine niedrige Viruslast im Blut nachgewiesen wurde
May 14, 2021 15:19 ET
|
Enochian Bioscience
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., ein Unternehmen, das sich auf zelluläre und immunologische Therapien mithilfe genetischer Veränderungen bei...
Enochian BioSciences annonce la présentation scientifique d'une personne atteinte du VIH avec des niveaux de virus dans le sang contrôlés pendant 255 jours après un traitement utilisant une nouvelle thérapie cellulaire
May 14, 2021 15:19 ET
|
Enochian Bioscience
LOS ANGELES, 14 mai 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., une société axée sur les thérapies cellulaires et immunitaires génétiquement modifiées pour les maladies infectieuses et le...
Enochian BioSciences kondigt een wetenschappelijke presentatie aan van een persoon met HIV met vertoning van gecontroleerde bloedniveaus van de virus gedurende 255 dagen na de behandeling met een Novel Cellular Therapy
May 14, 2021 15:19 ET
|
Enochian Bioscience
LOS ANGELES, May 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences Inc., een bedrijf dat zich richt op genetisch gemodificeerde cellulaire en immuuntherapieën bij infectieziekten en kanker, kondigde...